Literature DB >> 6234179

Effects of verapamil, diltiazem, nisoldipine and felodipine on sarcoplasmic reticulum.

T Wang, L I Tsai, A Schwartz.   

Abstract

Verapamil, diltiazem, nisoldipine and felodipine, calcium antagonist drugs with different chemical structures, were studied for their effects on activities of sarcoplasmic reticulum (SR) isolated from dog cardiac and rabbit skeletal muscles. Nisoldipine and felodipine exerted biphasic actions on both cardiac and skeletal SR Ca2+-ATPase with maximum activation of 40-60% occurring at 20-40 microM for nisoldipine and 30-40% occurring at 15-30 microM for felodipine. At higher drug concentrations, Ca2+-ATPase was inhibited. In the presence of oxalate the maximum activation of the Ca2+ uptake rates at 5-20 microM nisoldipine were 30-50% for cardiac SR and at 80-100 microM of the drug were 300-500% for skeletal SR. Felodipine inhibited the rate of Ca2+ uptake by dog cardiac SR, but activated Ca2+ uptake by rabbit skeletal SR with a maximum of 30-50% at 12-25 microM. At higher concentrations of the two drugs the rate of Ca2+ uptake was inhibited. In the absence of oxalate, i.e., limited transport, nisoldipine shortened the duration of time that Ca2+ was bound to the cardiac and skeletal SR, while the rate of release of Ca2+ from skeletal SR was stimulated. Felodipine at low concentrations similarly caused a premature release of Ca2+ from skeletal SR at a rapid rate; at high concentrations both drugs did not alter Ca2+ binding but delayed Ca2+ release. Unlike nisoldipine and felodipine, verapamil and diltiazem inhibited the rates of Ca2+ transport both in cardiac and skeletal SR. The two drugs inhibited Ca2+-ATPase in cardiac SR but activated the enzyme in skeletal SR.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234179     DOI: 10.1016/0014-2999(84)90001-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Calcium antagonists and their mode of action: an historical overview.

Authors:  W G Nayler; J S Dillon
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  The effects of felodipine and bepridil on calcium-stimulated calmodulin binding and calcium pumping ATPase of cardiac sarcolemma before and after removal of endogenous calmodulin.

Authors:  J M Lamers; P D Verdouw; J Mas-Oliva
Journal:  Mol Cell Biochem       Date:  1987-12       Impact factor: 3.396

3.  Ca2+-antagonists inhibit the N-methyltransferase-dependent synthesis of phosphatidylcholine in the heart.

Authors:  P S Tappia; K Okumura; K Kawabata; K R Shah; M S Nijjar; V Panagia; N S Dhalla
Journal:  Mol Cell Biochem       Date:  2001-05       Impact factor: 3.396

4.  Effects of verapamil on ischaemia-induced impairment of ATP-dependent calcium extrusion in rat heart sarcolemma.

Authors:  F T van Amsterdam; M M Goddijn; M Haas; N C Punt; J Zaagsma
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

5.  Comparative effects of bepridil, its quaternary derivative CERM 11888 and verapamil on caffeine-induced contracture in ferret hearts.

Authors:  J Leboeuf; C Leoty; J C Lamar; R Massingham
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

6.  Ca2+ entry-independent effects of L-type Ca2+ channel modulators on Ca2+ sparks in ventricular myocytes.

Authors:  Julio A Copello; Aleksey V Zima; Paula L Diaz-Sylvester; Michael Fill; Lothar A Blatter
Journal:  Am J Physiol Cell Physiol       Date:  2007-02-21       Impact factor: 4.249

7.  Improvement of relaxation velocity parameters by calcium channel blockers in the aging rabbit myocardium.

Authors:  N C Morcos; J M Gardin; N Tomita; W L Henry
Journal:  Basic Res Cardiol       Date:  1992 Sep-Oct       Impact factor: 17.165

Review 8.  The pharmacology of nisoldipine.

Authors:  A Knorr
Journal:  Cardiovasc Drugs Ther       Date:  1987-12       Impact factor: 3.727

9.  Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies.

Authors:  C R Jones; F Pasanisi; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

10.  Cardioprotective effects of 5-hydroxymethylfurfural mediated by inhibition of L-type Ca2+ currents.

Authors:  G Wölkart; A Schrammel; C N Koyani; S Scherübel; K Zorn-Pauly; E Malle; B Pelzmann; M Andrä; A Ortner; B Mayer
Journal:  Br J Pharmacol       Date:  2017-09-09       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.